KR102106152B1 - Manufacturing method of sambungnyawa jelly and the jellies thereby - Google Patents
Manufacturing method of sambungnyawa jelly and the jellies thereby Download PDFInfo
- Publication number
- KR102106152B1 KR102106152B1 KR1020180139279A KR20180139279A KR102106152B1 KR 102106152 B1 KR102106152 B1 KR 102106152B1 KR 1020180139279 A KR1020180139279 A KR 1020180139279A KR 20180139279 A KR20180139279 A KR 20180139279A KR 102106152 B1 KR102106152 B1 KR 102106152B1
- Authority
- KR
- South Korea
- Prior art keywords
- jelly
- extract
- manufacturing
- stevia
- weight
- Prior art date
Links
- 235000015110 jellies Nutrition 0.000 title claims abstract description 63
- 239000008274 jelly Substances 0.000 title claims description 53
- 238000004519 manufacturing process Methods 0.000 title claims description 20
- 239000000284 extract Substances 0.000 claims abstract description 63
- 238000000034 method Methods 0.000 claims abstract description 14
- 239000000654 additive Substances 0.000 claims description 28
- 241000544066 Stevia Species 0.000 claims description 27
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims description 27
- 230000000996 additive effect Effects 0.000 claims description 24
- 238000001914 filtration Methods 0.000 claims description 19
- 238000003756 stirring Methods 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 12
- 239000008213 purified water Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 9
- 238000000605 extraction Methods 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 235000019737 Animal fat Nutrition 0.000 claims description 6
- 108010010803 Gelatin Proteins 0.000 claims description 6
- 108010073771 Soybean Proteins Proteins 0.000 claims description 6
- 102000007544 Whey Proteins Human genes 0.000 claims description 6
- 108010046377 Whey Proteins Proteins 0.000 claims description 6
- 239000008273 gelatin Substances 0.000 claims description 6
- 229920000159 gelatin Polymers 0.000 claims description 6
- 235000019322 gelatine Nutrition 0.000 claims description 6
- 235000011852 gelatine desserts Nutrition 0.000 claims description 6
- 229940038580 oat bran Drugs 0.000 claims description 6
- 235000019871 vegetable fat Nutrition 0.000 claims description 6
- 238000003809 water extraction Methods 0.000 claims description 6
- 235000021119 whey protein Nutrition 0.000 claims description 6
- 229910021538 borax Inorganic materials 0.000 claims description 5
- 235000019197 fats Nutrition 0.000 claims description 5
- 239000004328 sodium tetraborate Substances 0.000 claims description 5
- 235000010339 sodium tetraborate Nutrition 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 229940001941 soy protein Drugs 0.000 claims description 5
- 239000003765 sweetening agent Substances 0.000 claims description 4
- 235000019482 Palm oil Nutrition 0.000 claims description 3
- 235000019483 Peanut oil Nutrition 0.000 claims description 3
- 244000299461 Theobroma cacao Species 0.000 claims description 3
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 claims description 3
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 claims description 3
- 235000014121 butter Nutrition 0.000 claims description 3
- 235000001046 cacaotero Nutrition 0.000 claims description 3
- 235000013351 cheese Nutrition 0.000 claims description 3
- 239000003240 coconut oil Substances 0.000 claims description 3
- 235000019864 coconut oil Nutrition 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 235000021323 fish oil Nutrition 0.000 claims description 3
- 235000003599 food sweetener Nutrition 0.000 claims description 3
- 235000013372 meat Nutrition 0.000 claims description 3
- 238000000465 moulding Methods 0.000 claims description 3
- 239000003921 oil Substances 0.000 claims description 3
- 235000019198 oils Nutrition 0.000 claims description 3
- 239000004006 olive oil Substances 0.000 claims description 3
- 235000008390 olive oil Nutrition 0.000 claims description 3
- 239000002540 palm oil Substances 0.000 claims description 3
- 239000000312 peanut oil Substances 0.000 claims description 3
- 239000003549 soybean oil Substances 0.000 claims description 3
- 235000012424 soybean oil Nutrition 0.000 claims description 3
- 235000021281 monounsaturated fatty acids Nutrition 0.000 claims description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims description 2
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 2
- 235000003441 saturated fatty acids Nutrition 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000019634 flavors Nutrition 0.000 claims 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 31
- 239000008280 blood Substances 0.000 abstract description 31
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 12
- 239000008103 glucose Substances 0.000 abstract description 12
- 240000008672 Gynura procumbens Species 0.000 abstract description 7
- 235000018457 Gynura procumbens Nutrition 0.000 abstract description 6
- 208000002249 Diabetes Complications Diseases 0.000 abstract description 3
- 235000019629 palatability Nutrition 0.000 abstract description 3
- 230000000144 pharmacologic effect Effects 0.000 abstract description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 30
- 230000002218 hypoglycaemic effect Effects 0.000 description 13
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 9
- 102000004877 Insulin Human genes 0.000 description 6
- 108090001061 Insulin Proteins 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 229940125396 insulin Drugs 0.000 description 6
- 210000000496 pancreas Anatomy 0.000 description 5
- 241000700159 Rattus Species 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 241000208340 Araliaceae Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 239000003472 antidiabetic agent Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 239000004463 hay Substances 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 240000004355 Borago officinalis Species 0.000 description 1
- 235000007689 Borago officinalis Nutrition 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 208000002705 Glucose Intolerance Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 206010067409 Trichophytosis Diseases 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 235000019206 astragalus extract Nutrition 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000010030 glucose lowering effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 229940126904 hypoglycaemic agent Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000022001 negative regulation of insulin secretion Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- -1 oatbran Proteins 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 201000009104 prediabetes syndrome Diseases 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/10—Marmalades; Jams; Jellies; Other similar fruit or vegetable compositions; Simulated fruit products
- A23L21/15—Marmalades; Jams; Jellies; Other similar fruit or vegetable compositions; Simulated fruit products derived from fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/34—Membrane process
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/50—Concentrating, enriching or enhancing in functional factors
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
본 발명은 삼붕초 젤리의 제조방법 및 그에 의한 젤리에 관한 것으로서, 보다 상세하게는 삼붕초를 이용하여 젤리를 제조함으로써, 당뇨합병증 예방에 효과가 있으며 무설탕, 저칼로리의 젤리를 제조할 수 있는 삼붕초 젤리의 제조방법 및 그에 의한 젤리에 관한 것이다.The present invention relates to a method of manufacturing a trilobite jelly and a jelly according to the same, and more specifically, by preparing a jelly using tribocho, it is effective in preventing diabetic complications and can produce a sugar-free, low-calorie jelly. It relates to a manufacturing method of jelly and a jelly thereby.
당뇨병이란 우리가 섭취한 음식물이 포도당으로 분해되어 영양분을 필요로 하는 우리 몸 각 부분(세포)으로 전달되지 못하고 오줌으로 배설되는 병이다. 제1형 당뇨병(선천성: 5%)은 췌장세포의 파괴로 인해 인슐린의 분비가 불가능 상태를 말하고, 제2형 당뇨병(후천성: 95%)은 인슐린저항성과 상대적인 인슐린 결핍으로 인해 혈당을 분해하지 못하는 경우이다. 일반적으로 정상 혈당치는 식전 공복혈당이 110mg/dl 미만이고, 당뇨가 진행 중인 내당능 장애 상태에서의 공복혈당은 125 mg/dl 이고 공복혈당이 126mg/dl 이상이면 당뇨로 판정한다.Diabetes is a disease in which food ingested by us is broken down into glucose, not delivered to each part (cell) of our body that needs nutrients, but excreted by urine. Type 1 diabetes (congenital: 5%) refers to a condition in which insulin cannot be secreted due to destruction of pancreatic cells, and type 2 diabetes (acquired: 95%) cannot break down blood sugar due to insulin resistance and relative insulin deficiency. It is the case. In general, the normal blood glucose level is determined as diabetes if the fasting blood sugar before meals is less than 110 mg / dl, the fasting blood sugar in the impaired glucose tolerance state is 125 mg / dl and the fasting blood sugar is 126 mg / dl or more.
당뇨병의 현상적인 원인은 췌장에서의 인슐린 분비 저해의 원인도 있지만 좀 더 근본적으로는 신체의 5장(간장,신장, 췌장, 심장, 폐) 6부(위장, 소장, 대장, 방광, 쓸개, 삼초)에 이상이 생기면서 서서히 혈압과 혈당이 상승하게 되기 때문이다. 특히 췌장, 신장, 간장의 기능이 현저히 떨어지면 혈당이 상승하여 당뇨병의 진행 속도가 빨라진다.The phenomenal cause of diabetes is the cause of inhibition of insulin secretion in the pancreas, but more fundamentally, the body's 5 chapters (hepatic, kidney, pancreas, heart, lung) part 6 (stomach, small intestine, large intestine, bladder, gallbladder, 3 seconds) ) As an abnormality occurs, blood pressure and blood sugar gradually increase. In particular, if the functions of the pancreas, kidney, and liver are significantly reduced, blood sugar rises, and diabetes progresses faster.
단순히 췌장에서의 인슐린 분비 부족으로 혈당이 상승하는 것, 또는 인슐린이 분비가 되더라도 작용을 하지 못하는 것, 그리고 췌장에서의 인슐린을 분비하는 베타세포의 파괴로 인슐린이 생산되지 않는 현상, 인슐린 샘구멍인 랑게르한스섬의 막힘 현상 등 이 모든 원인들을 지금까지 당뇨병 발병의 원인으로 보고 있으나, 이들은 당뇨병의 현상적, 표면적, 직접적 원인일 뿐이라서 이러한 원인을 제거하는 것이 당뇨병의 완치에 전혀 도움이 되지 못하고 있다.Insufficient insulin secretion in the pancreas, blood sugar rises, or insulin does not work even when it is secreted, and insulin is not produced due to the destruction of beta cells that secrete insulin from the pancreas. All of these causes, such as the blockage phenomenon, are considered to be the cause of diabetes, but these are only the phenomenal, superficial, and direct causes of diabetes, and eliminating these causes does not help at all to cure diabetes.
최근에는 우리나라에서도 당뇨 대란이라 할 만큼 당뇨병 발병률이 급상승하고 있다. 1970년대 전체인구의 1~3%수준의 당뇨병 발병률이 1980년대 3~10%로 증가하였으며, 2000년도에 이르러 전 국민의 약 10%가 당뇨환자이고, 그 중에 40대 이후 10명 중 4명은 본인도 모르게 당뇨가 현재 진행되고 있는 진행형 당뇨인 실정이다.In recent years, the incidence of diabetes has risen so rapidly that it is called the diabetes crisis. In the 1970s, the incidence of diabetes at the level of 1 ~ 3% of the total population increased to 3 ~ 10% in the 1980s, and by the year 2000, about 10% of all the people were diabetic, 4 out of 10 after 40s Without prior knowledge, diabetes is a progressive diabetes.
특히 2000년대 후반부터는 급속한 고령화 사회로 고혈압, 당뇨환자의 증가 추세가 급격히 증가하는 추세이지만, 현재 당뇨병 치료는 일반적으로 혈당강하제 복용, 인슐린 주사 및 식사통제 방법을 선택하여 치료하고 있지만, 이러한 방법들은 완치가 어려운 것이 현실이다. 전술한 당뇨병 치료법들은 단순히 혈당을 상승하지 못하게 억누르는 일종의 응급조치 수준의 방법으로서 강하제를 복용하지 않으면 혈당이 다시 상승하게 된다. In particular, since the late 2000s, a rapidly aging society, the trend of increasing hypertension and diabetes is rapidly increasing. Currently, diabetes treatment is usually treated by taking hypoglycemic drugs, insulin injections and dietary control, but these methods are completely cured. The difficult thing is reality. The above-mentioned diabetes treatments are a kind of first aid level method that simply suppresses blood sugar from rising, and if the drug is not taken, the blood sugar rises again.
대한민국 공개특허공보 제10-2012-0109061호에서는 효소전환 황기 추출물을 유효성분으로 함유하는 혈당강하 및 당뇨병 예방 또는 완화용 약제 및 그 제조방법에 대해 개시되고 있으나 이러한 약제 역시 혈당강화 효과가 일시적일 따름이다.Korean Patent Publication No. 10-2012-0109061 discloses a drug for preventing or alleviating blood sugar and preventing diabetes, which contains an enzyme-converted astragalus extract as an active ingredient, and a method for manufacturing the same, but these drugs also have a temporary effect of enhancing blood sugar. to be.
또한 녹차와 관련하여, 일본약학잡지 [일본茶의 혈당강하 성분에 관한 연구, 108권, 10호 964-970(1988)]에서는 당뇨병이 유발된 쥐에 녹차의 냉수추출, 온수추출, 열수추출한 엑기스의 혈당강하 작용 및 유효성분인 분자량 4만 정도의 다당체 성분에 관하여 기재되어 있으며, 일본생이학연구지 (말차(抹茶)의 당뇨병에 대한 실험적 연구)에서는 말차의 당뇨병에 대한 효과를 조사하기 위해 집토끼를 사용하여 말차 투여전과 투여후의 혈당치를 측정한 결과 11%-33% 범위의 혈당치 감소효과를 내는 등 말차의 당뇨병 억제효과에 관하여 기재되어 있다.In addition, in relation to green tea, the Japanese Pharmacy Magazine [A Study on the Components of Blood Glucose in Japan, Vol. 108, No. 10 964-970 (1988)] extracts cold water, hot water and hot water from green tea in diabetes-induced mice. It is described about the hypoglycemic action and the polysaccharide component of about 40,000 molecular weight, which is an active ingredient, and the Japanese Bioscience Journal (Experimental Study on Diabetes Mellitus) uses rabbits to investigate the effects of matcha on diabetes. It has been described with respect to the anti-diabetic effect of matcha, such as the result of measuring the blood glucose level before and after the use of matcha, and reducing the blood sugar level in the range of 11% -33%.
또한, 삼붕초는 명월초 또는 당뇨초 및 sambungnyawa(삼붕냐와) 라고도 불리우며, 학명으로는 Gynura procumbens(G. procumbens)로 불리워지며 국제적으로 잘 알려진 식물이다. 삼붕초는 전통 의학에서 당뇨병 치료에 널리 사용되며 저혈당 효과는 생체 내 연구에서 보고된 바 있고(Hamid et al., 2004 ; Algariri et al., 2014 ), 삼붕초는 당뇨병 동물에서만 저혈당 효과를 유도하는 특이성을 가지고 있으며, 당뇨병 래트(rat) 실험모델에서 당 공복 혈당 수치를 현저히 감소시키고 포도당 증가를 억제하는 것으로 나타났으나 정상 쥐에서는 그렇지 않았다(Zhang and Tan, 2000 ; Algariri et al., 2013)는 실험결과가 실제 논문에 개시되어 있을 정도로 당뇨병 치료에 우수한 효능을 가지는 식물이다.In addition, Samborcho is also known as Myeongwolcho or Diabetic and sambungnyawa (Sambunnyawa), and is also known internationally as Gynura procumbens (G. procumbens). Sambungcho is widely used in the treatment of diabetes in traditional medicine, and hypoglycemic effects have been reported in in vivo studies (Hamid et al., 2004; Algariri et al., 2014). It has a specificity, and in a diabetic rat experimental model, it has been shown to significantly reduce glucose fasting blood glucose levels and inhibit glucose increase, but not in normal mice (Zhang and Tan, 2000; Algariri et al., 2013). It is a plant with excellent efficacy in the treatment of diabetes to the extent that experimental results are disclosed in the actual paper.
이처럼, 삼붕초의 효능이 알려지면서 삼붕초는 생초, 건초, 분말 및 입상 등의 형태로 복용되어져 왔으나, 복용과 휴대, 수납관리 및 짧은 유통기한 등에 많은 불편이 발생하여 용이하게 섭취하는 것이 어려우며, 특히 건초, 분말 및 입상 형태로 삼붕초를 복용할 경우에는 물이 꼭 동반되어야 하기 때문에 섭취 시 번거롭고 식감저하, 삼붕초 고유의 맛과 향에 대한 거부감 등으로 대중화되어 있지 않은 실정이다.As such, as the effectiveness of Samborcho has been known, Samborcho has been taken in the form of raw grass, hay, powder, and granules, but it is difficult to ingest easily due to many inconveniences such as taking and carrying, storage management, and short shelf life. When taking Samborcho in the form of hay, powder, and granules, water must be accompanied, so it is cumbersome when consumed, and has not been popularized due to the lack of texture and the rejection of Samborcho's unique taste and aroma.
본 발명은 삼붕초를 이용한 혈당강하 효과를 나타내는 젤리 및 제형의 제조방법에 관한 것으로서, 더욱 상세하게는 단맛을 느끼게 하면서도 혈당강하 효과를 가지는 스테비아(stevia) 및 여러 종류의 혼합 생약조성물을 과학적으로 혼합 구성함으로써, 혈당을 정상수치로 유지시켜 당뇨합병증을 예방하기 위한 삼붕초 젤리의 제조방법 및 그에 의한 젤리를 제공하는데 그 목적이 있다.The present invention relates to a method of manufacturing a jelly and a formulation showing a hypoglycemic effect using trichophytosis, more specifically, stevia having various hypoglycemic effects while feeling sweetness, and various kinds of mixed herbal compositions scientifically By constituting, the purpose is to provide a method of manufacturing a trichophyll jelly for preventing diabetes complications by maintaining blood sugar at a normal level and a jelly thereby.
또한, 본 발명은 삼붕초를 간편하고 쉽게 섭취할 수 있으며, 맛에 대한 거부감 없이 식감이 향상되고 기호도가 우수한 삼붕초 젤리의 제조방법 및 그에 의한 젤리를 제공하는데 그 목적이 있다.In addition, the present invention can provide a simple and easy intake of trident, and the object is to provide a method of manufacturing a trichocho jelly with improved texture and excellent palatability without a feeling of refusal to taste.
본 발명의 일측면에 따르면, 본 발명의 실시 예들은 삼붕초 및 정제수를 1:4 내지 1:7 중량비율로 혼합하는 혼합단계(S1); 상기 혼합단계를 거친 삼붕초 및 정제수를 추출기에서 80℃ 내지 85℃에서 7시간 내지 9시간 추출하여 추출물을 얻는 추출단계(S2); 상기 추출물을 여과한 후, 제 1첨가제를 투입하여 교반하는 여과 및 교반단계(S3); 상기 여과 및 교반단계를 거친 추출물을 감압농축하여 삼붕초 추출물을 수득하는 추출물 제조단계(S4); 상기 삼붕초 추출물과 스테비아(stevia) 추출물, 대두단백질, 유청단백질, 오우트브랜(Oatbran) 및 젤라틴을 투입하는 제 2첨가제 투입단계(S5); 및 상기 제 2첨가제 투입단계를 거친 삼붕초 추출물 및 첨가제의 혼합물을 성형틀에 넣고 3℃ 내지 5℃로 냉각시켜 젤리를 제조하는 젤리 제조단계(S6);를 포함하는 삼붕초 젤리의 제조방법을 제공한다.According to an aspect of the present invention, the embodiments of the present invention include a mixing step (S1) of mixing the borage and purified water in a weight ratio of 1: 4 to 1: 7; Extraction step (S2) to obtain the extract by extracting 7 to 9 hours at 80 ℃ to 85 ℃ from the extractor Sambancho and purified water after the mixing step; After filtering the extract, a filtration and stirring step (S3) of stirring by adding a first additive; An extract preparation step (S4) of extracting the extract from the filtered and agitated step under reduced pressure to obtain a Samborcho extract; A second additive input step (S5) of adding the borax extract and stevia extract, soy protein, whey protein, oatbran and gelatin; And a jelly preparation step (S6) for preparing a jelly by putting a mixture of the extracts of Sambungcho and additives that have been subjected to the second additive injection step into a molding mold and cooling them to 3 ° C to 5 ° C. to provide.
상기 교반단계에서 제 1첨가제는 감미료, 향료, 천연색소를 사용할 수 있다.In the stirring step, the first additive may be used as a sweetener, fragrance, and natural color.
상기 제 2첨가제 투입단계에서 상기 스테비아 추출물은, 건조된 스테비아 잎을 분쇄하는 분쇄단계; 상기 분쇄된 스테비아 잎은 정제수 100 중량부에 대하여 스테비아 잎 2 내지 8 중량부를 투입하여 스테비아 추출물을 수득하는 열수추출단계; 및 상기 열수추출단계를 거친 스테비아 추출물을 여과시키는 여과단계;를 포함하여 추출될 수 있다.In the step of adding the second additive, the stevia extract comprises: a crushing step of crushing dried stevia leaves; The crushed stevia leaf is a hot water extraction step of adding 2 to 8 parts by weight of stevia leaves to 100 parts by weight of purified water to obtain a stevia extract; And a filtration step of filtering the stevia extract that has undergone the hot water extraction step.
상기 제 2첨가제 투입단계에서 식물성 지방 및 동물성 지방을 더 포함할 수 있다.In the step of adding the second additive, vegetable fat and animal fat may be further included.
상기 식물성 지방은 콩기름, 올리브유, 야자유, 코코넛유, 카카오 오일 및 땅콩유 중에서 선택된 적어도 하나 이상일 수 있다.The vegetable fat may be at least one selected from soybean oil, olive oil, palm oil, coconut oil, cacao oil, and peanut oil.
상기 동물성 지방은 버터, 치즈, 고기지방 및 생선기름 중에서 선택된 적어도 하나 이상일 수 있다.The animal fat may be at least one selected from butter, cheese, meat fat and fish oil.
상기 여과 및 교반단계에서 추출물의 여과는 상온에서 마이크로필터를 이용하여 여과할 수 있다.The filtration and the filtering of the extract in the stirring step can be filtered using a micro filter at room temperature.
상기 교반단계를 거친 추출물은 고형분 함량이 60% 내지 80%가 되도록 감압농축할 수 있다.The extract subjected to the stirring step may be concentrated under reduced pressure so that the solid content is 60% to 80%.
상기 삼붕초 젤리에 함유되는 지방은 포화지방산이 25중량% 내지 30중량%, 1가 불포화지방산이 25중량% 내지 30중량%, 다가불포화지방산이 45중량% 내지 50중량%가 포함될 수 있다.The fat contained in the trident jelly may include 25% to 30% by weight of saturated fatty acids, 25% to 30% by weight of monounsaturated fatty acids, and 45% to 50% by weight of polyunsaturated fatty acids.
본 발명에 따르면 삼붕초 추출물을 사용하여 젤리를 제조함으로써, 혈당강하효과가 우수한 젤리를 제조할 수 있다. According to the present invention, a jelly having excellent hypoglycemic effect can be prepared by preparing jelly using the extract of samborcho.
또한, 본 발명에 따르면 삼붕초 추출물을 사용하여 젤리를 제조함으로써, 삼붕초의 약리적 성분을 남녀노소 쉽게 섭취할 수 있는 효과가 있다.In addition, according to the present invention, by preparing a jelly using the extract of Sambancho, there is an effect that the pharmacological component of Sambancho can be easily consumed by all ages.
또한, 본 발명에 따르면 삼붕초 추출물을 사용하여 젤리를 제조함으로써, 기호도가 우수하고 식감이 향상된 삼붕초 젤리 제조방법 및 그에 의한 젤리를 제공할 수 있다.In addition, according to the present invention, by preparing a jelly using the extract of Sambancho, it is possible to provide a method of manufacturing a Sambocho jelly with improved palatability and improved texture, and the resulting jelly.
도 1은 본 발명의 삼붕초 젤리의 제조과정을 나타낸 작업 공정도이다.1 is a working process diagram showing the manufacturing process of the trilobite jelly of the present invention.
기타 실시예들의 구체적인 사항들은 상세한 설명 및 도면들에 포함되어 있다. Specific details of other embodiments are included in the detailed description and drawings.
본 발명의 이점 및 특징, 그리고 그것들을 달성하는 방법은 첨부되는 도면과 함께 상세하게 후술되어 있는 실시예들을 참조하면 명확해질 것이다. 그러나 본 발명은 이하에서 개시되는 실시예들에 한정되는 것이 아니라 서로 다른 다양한 형태로 구현될 수 있으며, 이하의 설명에서 어떤 부분이 다른 부분과 연결되어 있다고 할 때, 이는 직접적으로 연결되어 있는 경우뿐 아니라 그 중간에 다른 매체를 사이에 두고 연결되어 있는 경우도 포함한다. 또한, 도면에서 본 발명과 관계없는 부분은 본 발명의 설명을 명확하게 하기 위하여 생략하였다. Advantages and features of the present invention, and methods for achieving them will be clarified with reference to embodiments described below in detail together with the accompanying drawings. However, the present invention is not limited to the embodiments disclosed below, but may be implemented in various different forms. In the following description, when a part is connected to another part, it is only directly connected. It also includes cases where other media are connected in the middle. In addition, parts not related to the present invention in the drawings are omitted to clarify the description of the present invention.
이하, 첨부된 도면들을 참고하여 본 발명에 대해 설명하도록 한다.Hereinafter, the present invention will be described with reference to the accompanying drawings.
본 발명은, 혈당강하제로서 삼붕초 추출물 0.01 중량% 내지 20중량%를 포함하고, 설탕대체제로서 당알콜의 일종인 스테비아(stevia)를 투입하여 혈당상승을 억제하고 영양적으로 균형을 이루도록 하였으며, 지방, 대두단백질, 유청단백질, 오우트브랜(oatbran), 젤라틴의 첨가제를 투입한 고단백, 고식이섬유인 삼붕초 젤리 제조방법에 관한 것이다.The present invention, as a hypoglycemic agent containing 0.01% to 20% by weight of Samborcho extract, was introduced as a sugar substitute, stevia, a kind of sugar alcohol, to suppress blood sugar rise and to achieve nutritionally balanced fat, The present invention relates to a method for preparing a tribocholine jelly, a high protein and high dietary fiber with additives of soy protein, whey protein, oatbran, and gelatin.
도 1을 참조하여 본 발명의 실시예에 따른 삼붕초 젤리의 제조방법에 관하여 설명한다. 도 1은 본 발명의 삼붕초 젤리의 제조과정을 나타낸 작업 공정도이다.With reference to Figure 1 will be described with respect to the method of manufacturing a trilobite jelly according to an embodiment of the present invention. 1 is a working process diagram showing the manufacturing process of the trilobite jelly of the present invention.
도 1을 참조하면, 본 발명에 따른 삼붕초 젤리의 제조방법은 삼붕초 및 정제수를 1:4 내지 1:7 비율로 혼합하는 혼합단계(S1); 상기 혼합단계를 거친 삼붕초 및 정제수를 추출기에서 80℃내지 85℃에서 7시간 내지 9시간 추출하여 추출물을 얻는 추출단계(S2); 상기 추출물을 여과한 후, 제 1첨가제를 투입하여 교반하는 여과 및 교반단계(S3); 상기 교반단계를 거친 추출물을 감압농축하여 삼붕초 추출물을 수득하는 추출물 제조단계(S4); 상기 삼붕초 추출물과 스테비아(stevia) 추출물, 대두단백질, 유청단백질, 오우트브랜(Oatbran) 및 젤라틴을 투입하는 제 2첨가제 투입단계(S5); 및 상기 제 2첨가제 투입단계를 거친 삼붕초 추출물 및 첨가제의 혼합물을 성형틀에 넣고 3℃내지 5℃로 냉각시켜 젤리를 제조하는 젤리 제조단계(S6)를 제공한다.Referring to Figure 1, the method of manufacturing a tribocho jelly according to the present invention is a mixing step (S1) of mixing the tribocho and purified water in a ratio of 1: 4 to 1: 7; Extraction step (S2) to obtain the extract by extracting 7 to 9 hours at 80 ℃ to 85 ℃ from the extractor of the borax and purified water after the mixing step; After filtering the extract, a filtration and stirring step (S3) of stirring by adding a first additive; An extract preparation step (S4) in which the extract subjected to the stirring step is concentrated under reduced pressure to obtain a Samborcho extract; A second additive input step (S5) of adding the borax extract and stevia extract, soy protein, whey protein, oatbran and gelatin; And a jelly preparation step (S6) for preparing a jelly by putting a mixture of the extracts of samborcho and the additives that have been subjected to the second additive addition step into a mold and cooling them to 3 ° C to 5 ° C.
혼합단계(S1)에서는 삼붕초 및 정제수를 1:4 내지 1:7 비율로 혼합하는 단계이다. 상기 삼붕초는 줄기 및 잎을 사용할 수 있으며, 바람직하기로는 삼붕초 잎을 사용하는 것이 더욱 바람직하다.In the mixing step (S1), it is a step of mixing triborate and purified water in a ratio of 1: 4 to 1: 7. The stem and leaves may be used as the trilobite, and it is more preferable to use a trilobite leaf.
추출단계(S2)에서는 상기 혼합단계(S1)를 거친 삼붕초 및 정제수를 추출기에서 80℃내지 85℃에서 7시간 내지 9시간 추출하여 추출물을 수득한다. 상기 추출시간이 7시간 미만일 경우에는 삼붕초의 유효성분이 미추출될 수 있어 바람직하지 않으며, 상기 추출시간이 9시간을 초과할 경우에는 추출효율이 저하되며 추출물이 변질될 수 있어 바람직하지 않다.In the extraction step (S2), the extract of samborcho and purified water subjected to the mixing step (S1) is extracted from an extractor at 80 ° C or 85 ° C for 7 to 9 hours to obtain an extract. When the extraction time is less than 7 hours, it is not preferable because the active ingredient of Sambungcho may not be extracted, and when the extraction time exceeds 9 hours, the extraction efficiency decreases and the extract may be deteriorated, which is not preferable.
여과 및 교반단계(S3)에서는 상기 추출단계(S2)에서의 추출물을 여과한 후, 제 1첨가제를 투입하여 교반하는 단계이다. 상기 교반단계(S3)에서 제 1첨가제는 감미료, 향료, 천연색소를 사용할 수 있다. 또한, 상기 추출물의 여과는 상온에서 마이크로필터를 이용하여 여과하는 것이 바람직하다.In the filtration and stirring step (S3), the extract in the extraction step (S2) is filtered, and then the first additive is added and stirred. In the stirring step (S3), the first additive may be used as a sweetener, fragrance, and natural color. In addition, the filtration of the extract is preferably filtered using a micro filter at room temperature.
추출물 제조단계(S4)에서는 상기 교반단계(S3)를 거친 추출물을 감압농축하여 삼붕초 추출물을 수득하는 단계이다. 상기 여과 및 교반단계(S3)를 거친 추출물에 유당을 교반용해 시키고 80℃에서 고형분 함량이 60% 내지 80%가 되도록 감압농축하여 삼붕초 추출물을 수득한다. 또한, 상기 고형분 함량은 70% 내지 80%인 것이 더욱 바람직하다.In the extract preparation step (S4), the extract that has undergone the agitation step (S3) is concentrated under reduced pressure to obtain a Samborcho extract. The lactose was stirred and dissolved in the extract subjected to the filtration and stirring step (S3), and concentrated under reduced pressure at 80 ° C. to obtain a solid content of 60% to 80%, thereby obtaining a tridentus extract. In addition, the solid content is more preferably 70% to 80%.
제 2첨가제 투입단계(S5)에서는 상기 삼붕초 추출물과 스테비아(stevia) 추출물, 대두단백질, 유청단백질, 오우트브랜(Oatbran) 및 젤라틴을 투입한다.In the second step of adding the additive (S5), the extract of trichophyll and stevia, soy protein, whey protein, oatbran, and gelatin are added.
상기 제 2첨가제 투입단계에서 식물성 지방 및 동물성 지방을 더 포함할 수 있다. 상기 식물성 지방은 콩기름, 올리브유, 야자유, 코코넛유, 카카오 오일 및 땅콩유 중에서 선택된 적어도 하나 이상인 것이 바람직하다. 또한, 상기 동물성 지방은 버터, 치즈, 고기지방 및 생선기름 중에서 선택된 적어도 하나 이상인 것이 바람직하다. In the step of adding the second additive, vegetable fat and animal fat may be further included. The vegetable fat is preferably at least one selected from soybean oil, olive oil, palm oil, coconut oil, cacao oil and peanut oil. In addition, the animal fat is preferably at least one selected from butter, cheese, meat fat and fish oil.
또한, 상기 제 2첨가제 투입단계에서 상기 스테비아 추출물은, 건조된 스테비아 잎을 분쇄하는 분쇄단계; 상기 분쇄된 스테비아 잎은 정제수 100 중량부에 대하여 스테비아 잎 2 내지 8 중량부를 투입하여 스테비아 추출물을 수득하는 열수추출단계; 및 상기 열수추출단계를 거친 스테비아 추출물을 여과시키는 여과단계;를 포함하여 추출되는 것이 바람직하다.In addition, in the step of adding the second additive, the stevia extract comprises: a crushing step of crushing dried stevia leaves; The crushed stevia leaf is a hot water extraction step of adding 2 to 8 parts by weight of stevia leaves to 100 parts by weight of purified water to obtain a stevia extract; And a filtering step of filtering the stevia extract after the hot water extraction step.
스테비아는 중남미 열대 산간지방이 원산지인 여러해살이풀로서, 영하로 내려가는 곳에서는 뿌리마저 얼어 월동이 불가능한 식물이다. 잎과 줄기에는 단맛을 내는 '스테비오사이드'라는 성분이 들어 있는데 이것은 설탕의 당분보다 200~300배 높다. 본 발명에서는 설탕의 대체 성분으로서 스테비아 추출물을 투입하여 젤리를 제조함으로써, 당뇨환자들도 쉽게 섭취할 수 있는 장점이 있다.Stevia is a perennial plant native to tropical mountainous regions of Central and South America. It is a plant that cannot freeze even if its roots are frozen below zero. The leaves and stems contain a sweet ingredient called stevioside, which is 200 to 300 times higher than sugar. In the present invention, by introducing stevia extract as an alternative component of sugar to prepare jelly, there is an advantage that diabetic patients can easily ingest.
젤리 제조단계(S6)에서는 상기 제 2첨가제 투입단계(S5)를 거친 삼붕초 추출물 및 첨가제의 혼합물을 성형틀에 넣고 3℃내지 5℃로 냉각시켜 젤리를 제조하는 단계이다.In the jelly manufacturing step (S6), a mixture of the extract of the Samborcho extract and the additive that has been subjected to the second additive input step (S5) is placed in a molding mold and cooled to 3 ° C to 5 ° C to produce jelly.
<실험예 1><Experimental Example 1>
[삼붕초 젤리의 제조] [Preparation of ginseng jelly]
삼붕초 추출물은 삼붕초와 정제수를 1:6 비율로 혼합하여 추출기에 넣고 80℃에서 8시간 추출한 후 마이크로필터를 이용하여 상온에서 여과하고 그 여과액에 첨가제를 투입한 후 교반 용해시킨 후 80℃에서 고형분 함량이 70% 이상이 될 때까지 감압농축하여 삼붕초 추출물을 제조하였다. 상기 추출된 삼붕초 추출물, 스테비아, 대두단백질, 유청단백질, 오우트브랜 및 젤라틴을 투입한 삼붕초 추출물 및 제2첨가제의 혼합물을 성형틀에 넣은 후 4℃로 냉각시켜 삼붕초 젤리로 제조하였다.Samborcho extract is a mixture of samborcho and purified water in a ratio of 1: 6, placed in an extractor, extracted at 80 ° C. for 8 hours, filtered at room temperature using a micro filter, added with an additive to the filtrate, dissolved and stirred, and then 80 ° C. In the solid content was concentrated under reduced pressure until the content of 70% or more to prepare a trilobite extract. The mixture of the extracted extract, and the second additive was added to the mold, and was cooled to 4 ° C. to prepare a trichocholine jelly as a mixture of the trichocholine extract, stevia, soybean protein, whey protein, oatbran and gelatin.
[삼붕초 젤리의 혈당강하효과 시험][Test of hypoglycemic effect of ginseng jelly]
본 발명에 의해 제조된 삼붕초 추출물을 일정량 배합한 젤리 제품을 제조하고 일반쥐 및 당뇨병 유발쥐를 이용한 동물실험을 통하여 혈당강하효과를 입증하였다.A jelly product in which a predetermined amount of the Samborcho extract produced by the present invention was formulated was prepared, and the hypoglycemic effect was proved through animal experiments using normal mice and diabetic mice.
①혈당강하효과 시험방법① Test method for hypoglycemic effect
i) 공시 실험동물: 6주령 아이씨알 마우스(ICR Mouse) 각 10두i) Disclosure Experiment Animals: 10 each for 6 week old IRC Mouse
ii) 공시 시료: 일반젤리(control), 발명품-1(삼붕초 미첨가 젤리), 발명품-2(삼붕초 첨가 젤리)ii) Sample: General jelly (control), invention-1 (non-added jelly), invention-2 (with added jelly)
iii) 방법iii) Method
1) 당뇨병 유발쥐에 대한 혈당상승 억제효과 실험1) Experiment on the effect of suppressing blood sugar rise in diabetic mice
- 알록산(Alloxan)을 50㎎/㎏으로 투여하여 당뇨병이 유발된 쥐를 12시간 절식 후 공시시료를 2g/㎏으로 생리식염수에 녹여 경구 투여하였다. -Alloxan was administered at 50mg / kg, and diabetes-induced mice were fasted for 12 hours, and then the sample was dissolved orally administered in physiological saline at 2g / kg.
- 45분후, 90분후 혈당을 원 터치 II (존슨 & 존슨, 미국)를 사용하여 측정하였다.-After 45 minutes and 90 minutes, blood glucose was measured using One Touch II (Johnson & Johnson, USA).
2) 건강한 쥐에 대한 당부하 실험2) Glucose experiment on healthy mice
건강한 쥐를 12 시간 절식시킨 후 말토스 500㎎/㎏과 공시시료를 2g/㎏씩 섞어서 경구 투여 45분 후 혈당을 원 터치 II(존슨 & 존슨, 미국)를 사용하여 측정하였다.After fasting healthy rats for 12 hours, maltose was mixed with 500 mg / kg of test sample and 2 g / kg of test sample, and blood glucose was measured 45 minutes after oral administration using One Touch II (Johnson & Johnson, USA).
3) 혈당강하효과3) hypoglycemic effect
① 혈당강하효과 시험결과① Blood glucose lowering effect test result
i) 당뇨병 유발쥐에 대한 혈당상승 억제효과 시험결과i) Test results of blood sugar suppression effect on diabetic mice
(mg/100㎖)45 minutes after administration
(mg / 100ml)
(mg/100㎖)90 hours after administration
(mg / 100ml)
(mg/㎖)Blood sugar rise
(mg / ml)
효과율(%)Strengthening blood sugar
Effective rate (%)
ii) 건강한 쥐에 대한 당부하 시험결과ii) Glucose load test results on healthy mice
(mg/100㎖)Pre-dose blood sugar
(mg / 100ml)
(mg/100㎖)45 minutes after administration
(mg / 100ml)
(mg/100㎖)90 hours after administration
(mg / 100ml)
(mg/㎖)Blood sugar rise
(mg / ml)
효과율(%)Strengthening blood sugar
Effective rate (%)
상기 표 1, 표 2를 참조하면, 혈당강하 효과 시험결과에서 알 수 있듯이 설탕함량이 낮은 젤리를 대조군으로하여 혈당강하효과를 비교한 결과, 삼붕초 추출물을 첨가한 제품의 경우 당뇨병 유발쥐 및 건강한 쥐에서 각각 100% 이상의 혈당강하 효과를 나타내었다. Referring to Table 1 and Table 2, as can be seen from the hypoglycemic effect test results, as a result of comparing the hypoglycemic effect with jelly having a low sugar content as a control, diabetes-inducing rats and healthy in the case of products added with Samborcho extract Each of the rats showed a hypoglycemic effect of more than 100%.
또한 삼붕초가 첨가되지 않은 제품의 경우, 혈당강하효과가 나타났으나 삼붕초가 첨가된 제품에 비해 효과면에서는 매우 미미한 수준으로 혈당강하효과가 나타나는 것을 확인할 수 있었다.In addition, in the case of the product without the addition of samborcho, a hypoglycemic effect was observed, but it was confirmed that the effect of lowering the blood sugar level was very small in terms of the effect compared to the product with the addition of samborcho.
전술한 본 발명의 설명은 예시를 위한 것이며, 본 발명이 속하는 기술분야의 통상의 지식을 가진 자는 본 발명의 기술적 사상이나 필수적인 특징을 변경하지 않고서 다른 구체적인 형태로 쉽게 변형이 가능하다는 것을 이해 할 수 있을 것이다.The above description of the present invention is for illustration only, and those of ordinary skill in the art to which the present invention pertains can understand that it can be easily modified to other specific forms without changing the technical spirit or essential features of the present invention. There will be.
그러므로 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다. 예를 들어 단일형으로 설명되어 있는 각 구성요소는 분산되어 실시될 수도 있으며, 마찬가지로 분산된 것으로 설명되어 있는 구성요소들도 결합 된 형태로 실시될 수 있다.Therefore, it should be understood that the embodiments described above are illustrative in all respects and not restrictive. For example, each component described as a single type may be implemented in a distributed manner, and similarly, components described as distributed may be implemented in a combined form.
본 발명의 범위는 상세한 설명보다는 후술하는 특허청구범위에 의하여 나타내어지며, 청구범위의 의미 및 범위 그리고 그 균등 개념으로부터 도출되는 모든 변경 또는 변형된 형태가 본 발명의 범위에 포함되는 것으로 해석 되어야 한다.The scope of the present invention is indicated by the following claims rather than the detailed description, and all changes or modifications derived from the meaning and scope of the claims and their equivalent concepts should be interpreted to be included in the scope of the present invention.
Claims (10)
상기 혼합단계를 거친 삼붕초 및 정제수를 추출기에서 80℃내지 85℃에서 7시간 내지 9시간 추출하여 추출물을 얻는 추출단계(S2);
상기 추출물을 여과한 후, 제 1첨가제를 투입하여 교반하는 여과 및 교반단계(S3);
상기 여과 및 교반단계를 거친 추출물을 감압농축하여 삼붕초 추출물을 수득하는 추출물 제조단계(S4);
상기 삼붕초 추출물과 스테비아(stevia) 추출물, 대두단백질, 유청단백질, 오우트브랜(Oatbran) 및 젤라틴을 투입하는 제 2첨가제 투입단계(S5); 및
상기 제 2첨가제 투입단계를 거친 삼붕초 추출물 및 첨가제의 혼합물을 성형틀에 넣고 3℃내지 5℃로 냉각시켜 젤리를 제조하는 젤리 제조단계(S6);를 포함하는 삼붕초 젤리의 제조방법.Mixing step (S1) of mixing the three borcho and purified water in a weight ratio of 1: 4 to 1: 7;
Extraction step (S2) to obtain the extract by extracting 7 to 9 hours at 80 ℃ to 85 ℃ from the extractor of the borax and purified water after the mixing step;
After filtering the extract, a filtration and stirring step (S3) of stirring by adding a first additive;
An extract preparation step (S4) of extracting the extract from the filtered and agitated step under reduced pressure to obtain a Samborcho extract;
A second additive input step (S5) of adding the borax extract and stevia extract, soy protein, whey protein, oatbran and gelatin; And
Method of manufacturing a tribocho jelly comprising; a jelly preparation step (S6) to prepare a jelly by putting a mixture of the extracts of samborcho and the additives that have been subjected to the second additive input step into a molding mold and cooling them to 3 ° C to 5 ° C.
상기 교반단계에서 제 1첨가제는 감미료, 향료, 천연색소를 사용하는 것을 특징으로 하는 삼붕초 젤리의 제조방법.According to claim 1,
In the stirring step, the first additive is a method of manufacturing a trichophyll jelly, characterized in that a sweetener, flavor, and natural color are used.
상기 제 2첨가제 투입단계에서 상기 스테비아 추출물은,
건조된 스테비아 잎을 분쇄하는 분쇄단계;
상기 분쇄된 스테비아 잎은 정제수 100 중량부에 대하여 스테비아 잎 2 내지 8 중량부를 투입하여 스테비아 추출물을 수득하는 열수추출단계; 및
상기 열수추출단계를 거친 스테비아 추출물을 여과시키는 여과단계;를 포함하여 추출되는 것을 특징으로 하는 삼붕초 젤리의 제조방법.According to claim 1,
The stevia extract in the second additive input step,
A crushing step of crushing the dried stevia leaf;
The crushed stevia leaf is a hot water extraction step of adding 2 to 8 parts by weight of stevia leaves to 100 parts by weight of purified water to obtain a stevia extract; And
Method of producing a trident jelly, characterized in that it is extracted, including; filtering step of filtering the stevia extract after the hot water extraction step.
상기 제 2첨가제 투입단계에서 식물성 지방 및 동물성 지방을 더 포함할 수 있는 것을 특징으로 하는 삼붕초 젤리의 제조방법.According to claim 1,
Method of manufacturing a tribolic jelly, characterized in that it may further include a vegetable fat and animal fat in the second additive input step.
상기 식물성 지방은 콩기름, 올리브유, 야자유, 코코넛유, 카카오 오일 및 땅콩유 중에서 선택된 적어도 하나 이상인 것을 특징으로 하는 삼붕초 젤리의 제조방법.The method of claim 4,
The vegetable fat is a method of manufacturing a trilobite jelly, characterized in that at least one selected from soybean oil, olive oil, palm oil, coconut oil, cacao oil and peanut oil.
상기 동물성 지방은 버터, 치즈, 고기지방 및 생선기름 중에서 선택된 적어도 하나 이상인 것을 특징으로 하는 삼붕초 젤리의 제조방법.The method of claim 4,
The animal fat is butter, cheese, meat fat and at least one selected from fish oil, characterized in that the method of manufacturing a trident jelly.
상기 여과 및 교반단계에서 추출물의 여과는 상온에서 마이크로필터를 이용하여 여과하는 것을 특징으로 하는 삼붕초 젤리의 제조방법.According to claim 1,
The filtration and filtration of the extract in the stirring step is a method of manufacturing a trilobite jelly, characterized in that using a micro filter at room temperature.
상기 교반단계를 거친 추출물은 고형분 함량이 60% 내지 80%가 되도록 감압농축하는 것을 특징으로 하는 삼붕초 젤리의 제조방법.According to claim 1,
The extract after the stirring step is a method for producing trichophyll jelly, characterized in that it is concentrated under reduced pressure so that the solid content is 60% to 80%.
상기 삼붕초 젤리에 함유되는 지방은 포화지방산이 25중량% 내지 30중량%, 1가 불포화지방산이 25중량% 내지 30중량%, 다가불포화지방산이 45중량% 내지 50중량%가 포함되어 있는 것을 특징으로 하는 삼붕초 젤리.The method of claim 9,
The triglyceride jelly contains 25% by weight to 30% by weight of saturated fatty acids, 25% to 30% by weight of monounsaturated fatty acids, and 45% to 50% by weight of polyunsaturated fatty acids. Trident jelly.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180139279A KR102106152B1 (en) | 2018-11-13 | 2018-11-13 | Manufacturing method of sambungnyawa jelly and the jellies thereby |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180139279A KR102106152B1 (en) | 2018-11-13 | 2018-11-13 | Manufacturing method of sambungnyawa jelly and the jellies thereby |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102106152B1 true KR102106152B1 (en) | 2020-05-04 |
Family
ID=70732394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180139279A KR102106152B1 (en) | 2018-11-13 | 2018-11-13 | Manufacturing method of sambungnyawa jelly and the jellies thereby |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102106152B1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100697184B1 (en) * | 2006-01-06 | 2007-03-21 | 주식회사 농협고려인삼 | A functional food for a ginseng and mulberry and banaba and the producing method therof |
KR20080084007A (en) | 2007-03-14 | 2008-09-19 | 한국 한의학 연구원 | Diagnosis system of deficient and forceful pulse |
KR101001159B1 (en) * | 2010-06-09 | 2010-12-17 | 목포대학교산학협력단 | Composition for preventing or improving the diabete containing eriobotrya japonica extract |
KR20130041494A (en) * | 2011-10-17 | 2013-04-25 | 이윤재 | The composition for treating diabetes |
KR101551377B1 (en) * | 2014-10-08 | 2015-09-09 | 신성대학 산학협력단 | Healthy food using Gynura procumbens and method for manufacturing the same |
-
2018
- 2018-11-13 KR KR1020180139279A patent/KR102106152B1/en active IP Right Grant
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100697184B1 (en) * | 2006-01-06 | 2007-03-21 | 주식회사 농협고려인삼 | A functional food for a ginseng and mulberry and banaba and the producing method therof |
KR20080084007A (en) | 2007-03-14 | 2008-09-19 | 한국 한의학 연구원 | Diagnosis system of deficient and forceful pulse |
KR101001159B1 (en) * | 2010-06-09 | 2010-12-17 | 목포대학교산학협력단 | Composition for preventing or improving the diabete containing eriobotrya japonica extract |
KR20130041494A (en) * | 2011-10-17 | 2013-04-25 | 이윤재 | The composition for treating diabetes |
KR101551377B1 (en) * | 2014-10-08 | 2015-09-09 | 신성대학 산학협력단 | Healthy food using Gynura procumbens and method for manufacturing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1951275B1 (en) | Antiobesity composition | |
JP5432123B2 (en) | Novel use of cacao extract | |
KR100990260B1 (en) | Composition for treating or alleviating obesity or hyperlipidemia comprising black garlic extract | |
US6416795B1 (en) | Herbal extract composition for stress prevention and treatment | |
KR101691205B1 (en) | Composition comprising herbal extract for preventing or treating fatty liver disease | |
KR20070096434A (en) | Natural plant extract composition for prevention and recovery of hyperlipidemia and stroke, natural tee including the same as effective components and the preparation method thereof | |
CN106665775A (en) | Health-care biscuit capable of reducing blood sugar and preparation method thereof | |
KR102002298B1 (en) | Compositions for preventing, ameliorating or treating hyperuricemia or metabolic disorders associated with hyperuricemia comprising herbal extracts | |
KR101694739B1 (en) | Pharmaceutical composition comprising fermented Opuntia humifusa for preventing and treating obesity or complications thereof and method for preparing the same | |
KR101976941B1 (en) | Composition comprising an extract of Elaeagnus umbellata for preventing and treating diabetes mellitus | |
JPH09234018A (en) | Beverage and food product having preventing action on diabetic complication | |
KR102106152B1 (en) | Manufacturing method of sambungnyawa jelly and the jellies thereby | |
KR101784093B1 (en) | Manufacturing method of composition having anti-diabetic effect containing the extracts of fermented germinated brown rice and orstachys japonia | |
KR101159116B1 (en) | The method of preparing food for diet using madicin-materials of plants | |
KR101734325B1 (en) | Anti-diabetes composition comprising exptracts of banaba | |
EP2194994B1 (en) | Cocoa extract for use in improving skin health | |
WO2005094858A1 (en) | Antidiabetic composition | |
KR20140137288A (en) | Composition comprising an extract of Alpinia officinarum Hance for preventing and treating hangover or liver disease | |
KR102292059B1 (en) | Composition comprising of the extract of Cissus verticillata and Cyclopia Intermedia as an active ingredient for preventing or treating diabetic complication and diabetes | |
KR20150078622A (en) | Plum candy manufacturing method | |
KR19980072453A (en) | Confectionery composition for diabetic patients, which contains lettuce extract as a main ingredient | |
KR101819920B1 (en) | Manufacturing method of composition having anti-diabetic and anti-inflammatory effect containing the extracts of fermented germinated brown rice and cudrania tricuspidata | |
KR20110000250A (en) | Health-supplementary food utilizing natural material for the healthy prostate and method of manufacturing thereof | |
KR20160059152A (en) | Anti-obesity composition comprising Cirsium japonicum leaf extract as effective component | |
WO2008018638A1 (en) | Fat absorption inhibitor and food and drink using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |